Unlocking the Promise of Genome Editing to DeliverĀ Life-Changing Medicines

Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

Read More


Editas News

May 18, 2015
Editas Medicine Presents Data from Multiple Therapeutic Discovery Programs Emerging from its Genome Editing Platform at the ASGCT Annual Conference Read More

Publications & Abstracts

May 15, 2015
Therapeutic Editing of the HBB Locus Using the Endogenous HBD Locus as a Donor Template Read More

May 15, 2015
Staphyloccocus aureus Cas9 an alternative Cas9 for genome editing applications Read More

May 14, 2015
Characterization of Cas9-mediated genome editing in human T cells Read More

May 13, 2015
Biophysical Characterization and Direct Delivery of S. pyogenes Cas9 Ribonucleoprotein Complexes  Read More

May 13, 2015
Cas9-mediated genome editing in hematopoietic stem/progenitor cells  Read More